Alprazolam significantly improves the efficacy of granisetron in the prophylaxis of emesis secondary to moderately emetogenic chemotherapy in patients with breast cancer

Chemotherapy

Volumn 51, Issue 5, 2005, Pages 280-285

  Abali, Hüseyin ^a,c   Oyan, Başak ^b   Güler, Nilüfer ^a  

^a ANKARA NUMUNE HOSPITAL   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Alprazolam; Anthracycline; Breast cancer; Granisetron; Nausea; Vomiting

Indexed keywords

ALPRAZOLAM; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GRANISETRON;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; EVALUATION; FEMALE; HUMAN; NAUSEA; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REMISSION; VOMITING;

ALPRAZOLAM; ANTHRACYCLINES; ANTIEMETICS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CROSS-OVER STUDIES; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EPIRUBICIN; FEMALE; FLUOROURACIL; GRANISETRON; HUMANS; HYPNOTICS AND SEDATIVES; MIDDLE AGED; VOMITING;

EID: 23944488227     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087455     Document Type: Article

References (18)

1. Gralla RJ: Antiemetic therapy; in Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, Holland CF, Frei E: Cancer Medicine. London, Decker, 2000, pp 2243-2250.
2. Fernandez-Marcos A, Martin M, Sanchez JJ, Rodriguez-Lescure A, Casado A, Lopez Martin JA, et al: Acute and anticipatory emesis in breast cancer patients. Support Care Cancer 1996;4:370-377.
3. Hesketh PJ: Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting. Cancer Invest 2000;18:163-173.
4. Koizumi W, Tanabe S, Nagaba S, Higuchi K, Nakayama N, Saigenji K, et al: A double-blind, crossover, randomized comparison of granisetron and ramosetron for the prevention of acute and delayed cisplatin-induced emesis in patients with gastrointestinal cancer: Is patient preference a better primary endpoint? Chemotherapy 2003;49:316-323.
5. Tsavaris N, Tsoutsos H, Bacoyannis C, Mylonakis N, Karvounis N, Kozatsani-Halividi D, et al: Antiemetic efficacy of alprazolam in carboplatin-induced emesis. Chemotherapy 1991;37:364-370.
6. Tsavaris N, Charalambidis G, Pagou M, Karabelis A, Mylonakis N, Bacoyiannis C, et al: Comparison of ondansentron (GR 38032F) versus ondansentron plus alprazolam as antiemetic prophylaxis during cisplatin-containing chemotherapy. Am J Clin Oncol 1994;17:516-521.
7. Mori K, Saito Y, Tominaga K: Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis. Am J Clin Oncol 1993;16:338-341.
8. Tsavaris N, Tsoutsos H, Bacoyannis C, Mylonakis N, Karvounis N, Kozatsani-Halividi D, et al: Antiemetic efficacy of alprazolam in carboplatin-induced emesis. Chemotherapy 1991;37:364-370.
9. Lehoczky O, Bagameri A, Sarosi Z, Kulcsar T, Pulay T: Does the addition of an anxiolytic drug improve the anti-emetic effectiveness of the steroid and granisetron combination in the prophylaxis of cisplatin-induced vomiting (in Hungarian). Orv Hetil 2001;142:1681-1684.
10. Bauduer F, Coiffier B, Desablens B: Granisetron plus or minus alprazolam for emesis prevention in chemotherapy of lymphomas: A randomized multicenter trial. Granisetron Trialists Group. Leuk Lymphoma 1999;34:341-347.
11. Pinder KL, Ramirez AJ, Black ME, Richards MA, Gregory WM, Rubens RD: Psychiatric disorder in patients with advanced breast cancer: Prevalence and associated factors. Eur J Cancer 1993;29A:524-527.
12. Gottschalk LA, Hoigaard-Martin J: The emotional impact of mastectomy. Psychiatry Res 1986;17:153-167.
13. Hesketh PJ, Gralla RJ, du Bois A, Tonato M: Methodology of antiemetic trials: Response assessment, evaluation of new agents and definition of chemotherapy emetogenicity. Support Care Cancer 1998;6:221-227.
14. Aapro M, Cull A: Depression in breast cancer patients: The need for treatment. Ann Oncol 1999;10:627-636.
15. Akechi T, Okuyama T, Imoto S, Yamawaki S, Uchitomi Y: Biomedical and psychosocial determinants of psychiatric morbidity among postoperative ambulatory breast cancer patients. Breast Cancer ResTreat 2001;65:195-202.
16. Aragona M, Muscatello MR, Mesiti M: Depressive mood disorders in patients with operable breast cancer. J Exp Clin Cancer Res 1997;16:111-118.
17. Tamaki K, Nishida M, Hiraide H, Tamakuma S: Alprazolam for patients with psychotic symptoms or autonomic imbalance symptoms after breast cancer surgery. Gan To Kagaku Ryoho 1991;18:1337-1341.
18. Razavi D, Delvaux N, Farvacques C, De Brier F, Van Heer C, Kaufman L, et al: Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: A double-blind, placebo-controlled study assessing the usefulness of alprazolam. J Clin Oncol 1993;11:1384-1390.